The pharmaceutical supply chain is increasing in complexity and creating a demand for digital transformation in order to gain total supply chain visibility and control. Adopting scalable and cost-effective solutions will be mission-critical moving forward to ensure public safety and protect the bottom line.
In the recently released white paper, Controlant noted: “Real-time temperature monitoring and supply chain total visibility offers many benefits: proactive product waste reduction; exponential operational cost savings, including reduced time spent on quality review; faster release times; improved collaboration with logistics partners; shorter delivery times; and more accurate forecasting.”
The white paper, explores how technology enables enterprises to better monitor, measure, and manage the supply chain, mitigate risk, drive continuous improvement, and generate substantial cost savings and ROI.
“When shipping pharmaceutical products by air freight, real-time monitoring provides critical visibility of shipments while at the airports. Airlines cannot always guarantee storage within their temperature-controlled facilities, which are often treated on a first-come, first-served basis as storage space allows.
“Tracking a shipment to China by air, several benefits were realised. The customer started receiving alerts on day two while the goods were stored at the airport. Due to cold ambient temperatures at the originating airport, the temperature began to decrease.
“Upon contacting their freight forwarder, the customer learned that their shipment of pallets was at the airport handling facility and due to capacity issues was not held in temperature-controlled storage. Contacting the airline in a timely fashion and explaining the severity of the issue, the onsite staff agreed to move the pallets into the temperature-controlled storage facility.
“Soon after, the temperature fell within the acceptable boundaries. Receiving alerts in real-time allowed for immediate action to rectify the deviation from temperature standards. The products were exposed to a minor excursion for a short period of time. This resulted in the shipment, valued at several million dollars, passing the QA requirements and release of the products to the market upon their arrival.”